Abstract
It is recognized as a promising therapeutic strategy for cocaine use disorder to develop an efficient enzyme which can rapidly convert cocaine to physiologically inactive metabolites. We have designed and discovered a series of highly efficient cocaine hydrolases, including CocH5-Fc(M6) which is the currently known as the most efficient cocaine hydrolase with both the highest catalytic activity against (−)-cocaine and the longest biological half-life in rats. In the present study, we characterized the time courses of protein appearance, pH, structural integrity, and catalytic activity against cocaine in vitro and in vivo of a CocH5-Fc(M6) bulk drug substance produced in a bioreactor for its in vitro and in vivo stability after long-time storage under various temperatures (− 80, − 20, 4, 25, or 37 °C). Specifically, all the tested properties of the CocH5-Fc(M6) protein did not significantly change after the protein was stored at any of four temperatures including − 80, − 20, 4, and 25 °C for ~ 18 months. In comparison, at 37 °C, the protein was less stable, with a half-life of ~ 82 days for cocaine hydrolysis activity. Additionally, the in vivo studies further confirmed the linear elimination PK profile of CocH5-Fc(M6) with an elimination half-life of ~ 9 days. All the in vitro and in vivo data on the efficacy and stability of CocH5-Fc(M6) have consistently demonstrated that CocH5-Fc(M6) has the desired in vitro and in vivo stability as a promising therapeutic candidate for treatment of cocaine use disorder.
Original language | English |
---|---|
Article number | 10952 |
Journal | Scientific Reports |
Volume | 14 |
Issue number | 1 |
DOIs | |
State | Published - Dec 2024 |
Bibliographical note
Publisher Copyright:© The Author(s) 2024.
Funding
This work was supported by the National Institutes of Health (NIH Grants U01 DA051079, UH2/UH3 DA041115, R01 DA056646, UG3/UH3 NS134920, U18 DA052319, R01 DA035552, R01 DA032910, and R01 DA013930).
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | R01 DA035552, UG3/UH3 NS134920, R01 DA013930, U01 DA051079, UH2/UH3 DA041115, R01 DA056646, R01 DA032910, U18 DA052319 |
National Institutes of Health (NIH) |
Keywords
- Cocaine abuse
- Cocaine hydrolase
- Enzyme therapy
- Pharmacokinetics
- Protein stability
ASJC Scopus subject areas
- General